Report cover image

The Worldwide Market for Liquid Biopsy (by Analyte [ctDNA, cfDNA, Other], by Application - Screening/Drug Monitoring/Diagnostic, by Region [US, Europe, Asia, ROW] and by Type of Cancer)

Published Jul 07, 2017
Length 210 Pages
SKU # KLI15405872

Description

The Worldwide Market for Liquid Biopsy

This report covers the market for liquid biopsy, including cfDNA, CTC and other technologies. The market data in this report is segmented by those technologies type of cancer tested and by purpose - testing, screening, drug monitoring. Companies are profiled and the top ten companies are ranked and their recent activities detailed.

Companies covered Include:

cfDNA-based Liquid Biopsy
Adaptive Biotechnologies  
Biodesix  
Epigenomics  
Foundation Medicine  
Genomic Health  
Guardant Health  
Myriad Genetics  
Pathway Genomics  
Personal Genome Diagnostics  
Qiagen 
Roche Diagnostics  
Sysmex-Inostics  
Trovagene
In Development Projects 
Adaptive Biotechnologies  
Biocartis  
Epigenomics  
Exact Sciences  
Foundation Medicine  
Genomic Health  
GRAIL  
Inivata  
Natera  
 
CTC-based Liquid Biopsy
Biocept 
Cynvenio Biosystems  
Epic Sciences  
GILUPI  
Menarini-Silicon Biosystems  
Qiagen  
Angle  
Biocept  
Epic Sciences  
Janssen Diagnostics 

Extracellular Vesicles-based Liquid Biopsy
Biodesix
Exosome Diagnostics
Gensignia
Hologic

The report contains:

  • Market Sizing
  • Market Forecasts to 2021
  • Products in Development
  • Trends and Issues
  • Company Profiles
  • Market Segmentation (Analyte, Purpose, Cancer Type)
  • Overview of Technologies
  • World Markets Segmented By Region

Table of Contents

210 Pages
    • Introduction
    • Liquid Biopsy Technologies
    • Industry Structure
    • Liquid Biopsy Market Revenues and Forecast
    • Introduction
    • Current Major Liquid Biopsy Technologies
    • Introduction
    • Advantages and Limitations of ctDNA in Liquid Biopsy
    • Current ctDNA-based Liquid Biopsy Tests
    • cctDNA-based Liquid Biopsy Tests in Development
    • Introduction
    • Challenges in the Development of CTCs-based Liquid Biopsy Tests
    • CTCs-based Liquid Biopsy Tests
    • CTCs-based Liquid Biopsy Tests in Development
    • Introduction
    • Liquid Biopsy Tests Based on Extracellular Vesicles
    • Introduction
    • Tiers of Competition
    • Competitive Factors
    • Significant Market Trends
    • Market Snapshot
    • Market Forecast
    • Circulating Tumor DNA
    • Circulating Tumor Cells
    • Extracellular Vesicles/ Other Analytes
    • Therapy Guidance and Monitoring
    • Diagnosis/ Screening
    • Disease Prognosis
    • Breast Cancer
    • Colorectal Cancer
    • Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Other Cancers
    • Top Ten Companies in the Liquid Biopsy Market
    • Biocept, Inc.
    • Epigenomics
    • Foundation Medicine, Inc.
    • Genomic Health
    • Guardant Health, Inc.
    • Menarini-Silicon Biosystems
    • Myriad Genetics, Inc.
    • NeoGenomics
    • QIAGEN N.V.
    • Roche Diagnostics
    • Other Companies Activating in the Liquid Biopsy Market
    • Angle, plc
    • Biocartis
    • Biodesix
    • Cynvenio Biosystems
    • Epic Sciences
    • Exact Sciences
    • Exosome Diagnostics, Inc.
    • Gensignia
    • GILUPI Gmbh
    • GRAIL
    • Hologic, Inc.
    • Inivata
    • MDxHealth
    • Natera
    • OncoCyte
    • Pathway Genomics
    • Personal Genome Diagnostics
    • Resolution Biosciences
    • Rosetta Genomics
    • Sysmex-Inostics, Inc.
    • Trovagene, Inc.
    • Vermillion, Inc.
    • VolitionRx
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.